Results 11 to 20 of about 22,774,664 (248)

CT predicts intraprocedural hemodynamics with computational fluid dynamics in TMVR-ineligible patients undergoing M-TEER. [PDF]

Front Cardiovasc Med
\(\bf Background:\) Hemodynamic outcomes in patients undergoing transcatheter mitral edge-to-edge repair (M-TEER) are difficult to predict. Computational fluid dynamics (CFD) is frequently used in biomedical engineering to simulate blood flow patterns ...
Kirchner J, Gerçek M, Omran H, Kassar M, Gräni C, Praz F, Rudolph F, Rudolph V, Rudolph TK.   +8 more
europepmc   +4 more sources

Prognostic impact of being underweight in patients undergoing mitral TEER: The OCEAN‐Mitral registry

ESC Heart Failure
Aims Mitral transcatheter edge‐to‐edge repair (M‐TEER) is a valid treatment option for severe mitral regurgitation (MR), necessitating accurate risk stratification of M‐TEER candidates for effective patient selection, optimal periprocedural care and ...
Ryosuke Higuchi, Masaki Izumo, Yuki Izumi, Mike Saji, Mitsuaki Isobe, Yoshihiro Akashi, Masanori Yamamoto, Masahiko Asami, Yusuke Enta, Masaki Nakashima, Shinichi Shirai, Shingo Mizuno, Yusuke Watanabe, Makoto Amaki, Kazuhisa Kodama, Junichi Yamaguchi, Toru Naganuma, Hiroki Bota, Yohei Ohno, Masahiro Yamawaki, Hiroshi Ueno, Kazuki Mizutani, Shunsuke Kubo, Toshiaki Otsuka, Kentaro Hayashida, the OCEAN‐Mitral Investigators   +25 more
doaj   +2 more sources

Screening and Procedural Guidance for Mitral Transcatheter Edge-to-Edge Repair (M-TEER). [PDF]

J Clin Med
International audienceMitral regurgitation (MR) is a common valvular heart disease associated with significant morbidity and mortality. For patients at high or prohibitive surgical risk, mitral transcatheter edge-to-edge repair (M-TEER) offers a less ...
Zygouri A, Rasmeehirun P, L'Official G, Papadopoulos K, Ikonomidis I, Donal E.   +5 more
europepmc   +2 more sources

A Low-Cost and Customizable TEER Meter for the Measurements of Cellular Barrier Integrity [PDF]

, 2019
A low-cost and translational TEER (trans-endothelial/epithelial electric resistance) meter was designed, fabricated, validated, and applied in this paper. TEER is a critical tool to quantitate the integrity of biological barriers.
Curtis G. Jones (8129254), Chengpeng, Chen, Chengpeng Chen (7822127), Curtis G., Jones   +3 more
core   +2 more sources

Spatial trans-epithelial electrical resistance (S-TEER) integrated in organs-on-chips [PDF]

, 2022
Transepithelial/transendothelial electrical resistance (TEER) is a label-free assay that is commonly used to assess tissue barrier integrity. TEER measurement systems have been embedded in organ-on-a-chip devices to provide live readouts of barrier ...
Ronny A Barnea, Rossana Rauti, Yael Leichtmann-Bardoogo, Ben M Maoz, Noa Renous, Mark D Kiri   +5 more
core   +1 more source

Change in TEER Value (%).

, 2022
Change in TEER Value (%).
Ryosuke Miyasaka (6623258), Roslyn Hayman (6623264), Kenichi Kaneko (12569111)   +2 more
core   +1 more source

A pattern learning-based method for temporal expression extraction and normalization from multi-lingual heterogeneous clinical texts

BMC Medical Informatics and Decision Making, 2018
Background Temporal expression extraction and normalization is a fundamental and essential step in clinical text processing and analyzing. Though a variety of commonly used NLP tools are available for medical temporal information extraction, few work is ...
Tianyong Hao, Xiaoyi Pan, Zhiying Gu, Yingying Qu, Heng Weng   +4 more
doaj   +1 more source

Efficacy and Safety of Transcatheter Mitral Valve Edge-to-Edge Repair with a MitraClip Device in Real-World Canadian Practice

CJC Open
Background: Mitral transcatheter edge-to-edge repair (M-TEER) is a treatment option for patients with symptomatic mitral regurgitation (MR). The real-world experience with M-TEER in Canada has not been reported previously.
Shamir R. Mehta, MD, MSc, Anita Asgar, MD, Robert Boone, MD, Josep Rodes-Cabau, MD, PhD, Eric A. Cohen, MD, Andrew Czarnecki, MD, Marino Labinaz, MD, Shahar Lavi, MD, Nicolo Piazza, MD, Kevin R. Bainey, MD, Akshay Bagai, MD, Jean-Michel Paradis, MD, J.D. Schwalm, MD, Douglas Wright, MD, Helen Nguyen, BSc, Tara McCready, PhD, Rajibul Mian, PhD, John Webb, MD, Neil Fam, MD   +18 more
doaj   +1 more source

Safety and Prognostic Implications of Mechanical Circulatory Support‐Assisted Transcatheter Edge‐to‐Edge Repair: The OCEAN‐Mitral Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Transcatheter edge‐to‐edge repair of the mitral valve (M‐TEER) has demonstrated promising outcomes for patients with mitral regurgitation who are unsuitable for surgical intervention.
Shuhei Tanaka, Teruhiko Imamura, Ryuichi Ushijima, Makiko Nakamura, Nobuyuki Fukuda, Hiroshi Ueno, Koichiro Kinugawa, Masanori Yamamoto, Shunsuke Kubo, Yuki Izumi, Mike Saji, Masahiko Asami, Yusuke Enta, Shinichi Shirai, Masaki Izumo, Shingo Mizuno, Yusuke Watanabe, Makoto Amaki, Kazuhisa Kodama, Hisao Otsuki, Toru Naganuma, Hiroki Bota, Yohei Ohno, Masahiro Yamawaki, Gaku Nakazawa, Daisuke Hachinohe, Toshiaki Otsuka, Kentaro Hayashida   +27 more
doaj   +1 more source

Clinical Failure After Mitral Transcatheter Edge-to-Edge Repair Mechanisms, Outcomes, and Management

Structural Heart
Transcatheter repair with edge-to-edge therapy (M-TEER) has been a revolutionary technology for patients with mitral regurgitation (MR). M-TEER is an established safe and effective treatment that alleviates MR, improves quality of life, and, in some ...
Paul Sorajja, MD, Siddharth Singh, MD, Robert Burke, MD, Philip Gideon, MD, Kenith Fang, MD, David Rizik, MD   +5 more
doaj   +1 more source